Owner GlaxoSmithKline LLC

Inventors Morgan, Barry; Hale, Stephen; AricoMuendel, Christopher C.; Clark, Mathew; Wagner, Richard; Israel, Davide I.; Gefter, Malcolm L.; Benjamin, Dennis; Hansen, Nils Jacob Vest; Kavarna, Malcolm J.; Creaser, Steffan Phillip; Franklin, George J.; Centrella, Paolo A.; Acharya, Raksha A.

Agent Davies Collison Cave

Pub. Number AU-A-2011205057

Parent 2004299145

Filing date 28 July 2011

Wipo publication date 18 August 2011

C07H 21/00 (1970.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07B 61/00 (2006.01) Other general methods

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/00 (2006.01) General processes for the preparation of peptides

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12P 19/34 (1970.01) Preparation of compounds containing saccharide radicals

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids